http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8#head http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8#assertion http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8#provenance http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8#assertion http://rdf.disgenet.org/resource/gda/DGN5cc00a5eb6d1634c1574411353275699 http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/1956 http://rdf.disgenet.org/resource/gda/DGN5cc00a5eb6d1634c1574411353275699 http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C0007131 http://rdf.disgenet.org/resource/gda/DGN5cc00a5eb6d1634c1574411353275699 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001122 http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8#provenance http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8#assertion http://purl.org/dc/terms/description [In patients with NSCLC and EGFR-activating mutations, a dose of erlotinib 25 mg/d (equivalent to gefitinib 250 mg/d) leads to impressive response rates and progression-free survival similar to the growing experience with the approved doses of gefitinib (250 mg/d) and erlotinib (150 mg/d).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/20512075 http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://purl.org/dc/terms/created 2017-10-17T13:12:13+02:00 http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP321564.RAcgiGM3YPYzxr-7fF6euAoVxGhV_7O_bmcSdLu6UiZz8 http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0